Evidence map›Paper›PMID 39752117›Full record

ArticleBulletin of mathematical biology2025

Prevalence Estimation Methods for Time-Dependent Antibody Kinetics of Infected and Vaccinated Individuals: A Markov Chain Approach.

Prajakta Bedekar, Rayanne A Luke, Anthony J Kearsley

Abstract read
In one paragraph

Article in Bulletin of mathematical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Prajakta Bedekar *Department of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, Maryland, 21218, USA.
Rayanne A Luke *Information Technology Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland, 20899, USA. rluke@gmu.edu.ORCID http://orcid.org/0000-0002-1636-8438
Anthony J KearsleyInformation Technology Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland, 20899, USA.

Funding

NIST PREP 70NANB18H162
6 · The paper itself

Abstract

Immune events such as infection, vaccination, and a combination of the two result in distinct time-dependent antibody responses in affected individuals. These responses and event prevalence combine non-trivially to govern antibody levels sampled from a population. Time-dependence and disease prevalence pose considerable modeling challenges that need to be addressed to provide a rigorous mathematical underpinning of the underlying biology. We propose a time-inhomogeneous Markov chain model for event-to-event transitions coupled with a probabilistic framework for antibody kinetics and demonstrate its use in a setting in which individuals can be infected or vaccinated but not both. We conduct prevalence estimation via transition probability matrices using synthetic data. This approach is ideal to model sequences of infections and vaccinations, or personal trajectories in a population, making it an important first step towards a mathematical characterization of reinfection, vaccination boosting, and cross-events of infection after vaccination or vice versa.

Indexed as

Markov ChainsMathematical ConceptsModels, ImmunologicalVaccinationAntibodiesAntibody FormationCommunicable DiseasesComputer SimulationHumansKineticsPrevalenceTime FactorsAntibodiesAntibody testingDiagnosticsMarkov chain modelsPrevalence estimationTime-dependence

Identifiers

PMID39752117
PMCPMC11698776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.